Targeting Triple Negative BREAst Cancer Metabolism With a Combination of Chemoimmunotherapy and a FASTing-like Approach in the Preoperative Setting: the BREAKFAST 2 Trial
Clinical trial NCT05763992 · UNKNOWN
Trial details
- NCT number
- NCT05763992
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-15
- Primary completion
- 2025-05-15
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.